Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?

Roberto Iezzi, Maurizio Pompili, Salvatore Agnes, Felice Giuliante, Francesca Romana Ponziani, Alessandra Cassano, Antonio Gasbarrini, Riccardo Manfredi, Massimo Siciliano, Brigida Eleonora Annicchiarico, Lucia Cerrito, Michele Basso, Anna Maria De Gaetano

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

N/A
Original languageEnglish
Pages (from-to)32-37
Number of pages6
JournalEuropean Journal of Radiology
Volume114
DOIs
Publication statusPublished - 2019

Keywords

  • Aged
  • Aged, 80 and over
  • Bleeding
  • Blood Loss, Surgical
  • Carcinoma, Hepatocellular
  • Catheter Ablation
  • Chemoembolization
  • Chemoembolization, Therapeutic
  • Combined Modality Therapy
  • Combined treatment
  • Feasibility Studies
  • Female
  • HCC
  • Humans
  • Liver Neoplasms
  • Male
  • Middle Aged
  • Personalized medicine
  • Precision Medicine
  • Precision medicine
  • Prospective Studies
  • Radiofrequency ablation
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?'. Together they form a unique fingerprint.

Cite this